Decreased CD14 + CCR2 + monocytes in active multiple sclerosis

Neuroscience Letters

Volumn 363, Issue 2, 2004, Pages 187-189

  Nakajima, Hideto ^a   Sugino, Masakazu ^a   Kimura, Fumiharu ^a   Hanafusa, Toshiaki ^a   Ikemoto, Toshiyuki ^a   Shimizu, Akira ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

CCR2; MCP 1; Multiple sclerosis; Th1; Th2

Indexed keywords

CD14 ANTIGEN; CHEMOKINE RECEPTOR CCR2;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; HUMAN; MALE; MONOCYTE; MULTIPLE SCLEROSIS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL; TH2 CELL;

ADULT; ANTIGENS, CD14; ANTIGENS, CD4; DOWN-REGULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; MONOCYTES; MULTIPLE SCLEROSIS; RECEPTORS, CHEMOKINE; TH1 CELLS; TH2 CELLS;

EID: 2542498744     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.04.006     Document Type: Article

References (19)

1. Balashov K.E., Rottman J.B., Weiner H.L., Hancock W.W. CCR5+ and CXCR3+T cells are increased in multiple sclerosis and their ligands MIP-1α and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. USA. 96:1999;6873-6878
2. Bergh F.T., Dayyani F., Ziegler-Heitbrock L. Impact of type-I-interferon on monocyte subsets and their differentiation to dendritic cells. An in vivo and ex vivo study in multiple sclerosis patients treated with interferon-beta. J. Neuroimmunol. 146:2004;176-188
3. Bettelli E., Das M.P., Howard E.D., Weiner H.L., Sobel R.A., Kuchroo V.K. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J. Immunol. 161:1998;3299-3306
4. Bonecchi R., Bianchi G., Bordingnon P.P., D'Ambrosio D., Lang R., Brosatti A., Sozzani S., Allavena P., Gray P.A., Montovani A., Sinigaglia F. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 helper cells (Th1s) and Th2s. J. Exp. Med. 187:1998;129-134
5. Brettschneider J., Ecker D., Bitsch A., Bahner D., Bogumil T., Dressel A., Elitok E., Kitze B., Poser S., Weber F., Tumani H. The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b. J. Neuroimmunol. 133:2002;193-197
6. Brück W., Porada P., Poser S., Rieckmann P., Hanefeld F., Kretzschmar H.A., Lassmann H. Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann. Neurol. 38:1995;788-796
7. Gu L., Tseng S., Horner R.M., Tam C., Loda M., Rollins B.J. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature. 404:2000;407-411
8. Hohlfeld R., Londei M., Massacesi L., Salvetti M. T-cell autoimmunity in multiple sclerosis. Immunol. Today. 16:1995;259-261
9. Kouwenhoven M., Teleshova N., Ozenci V., Press R., Link H. Monocytes in multiple sclerosis: phenotype and cytokine profile. J. Neuroimmunol. 112:2001;197-205
10. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology. 33:1983;1444-1452
11. Mahad D.J., Howell S.J., Woodroofe M.N. Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 72:2002;498-502
12. Mahad D.J., Ransohoff R.M. The role of MCP-1 (CCL2) and CCR2 in multiple sclerosis and experimental autoimmune encephalomyelitis (EAE). Semin. Immunol. 15:2003;23-32
13. Nakajima H., Kobayashi M., Pollard R.B., Suzuki F. Monocyte chemoattractant protein-1 enhances HSV-induced encephalomyelitis by stimulating Th2 responses. J. Leukoc. Biol. 70:2001;374-380
14. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., Tourtelotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13:1983;227-231
15. Rinner W.A., Bauer J., Schmidts M., Lassmann H., Hickey W.F. Resident microglia and hematogenous macrophages as phagocytes in adoptively transferred experimental autoimmune encephalomyelitis: an investigation using rat radiation bone marrow chimeras. Glia. 14:1995;257-266
16. Sorensen T.L., Tani M., Jensen J., Pierce V., Lucchinetti C., Folcik V.A., Qin S., Rottman J., Sellebjerg F., Strieter R.M., Frederiksen J.L., Ransohoff R.M. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103:1999;807-815
17. Sorensen T.L., Trebst C., Kivisakk P., Klaege K.L., Majmudar A., Ravid R., Lassmann H., Olsen D.B., Strieter R.M., Ransohoff R.M., Sellebjerg F. Multiple sclerosis: a study of CXCL10 and CXCR3 co-localization in the inflamed central nervous system. J. Neuroimmunol. 127:2002;59-68
18. Yu M., Johnson J.M., Tuohy V.K. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis. J. Neurosci. Res. 45:1996;463-470
19. Zang Y., Hong J., Robinson R., Li S., Rivera V.M., Zhang J.Z. Immune regulatory properties and interactions of copolymer-I and β-interferon 1a in multiple sclerosis. J Neuroimmunol. 137:2003;144-153